248 related articles for article (PubMed ID: 10828727)
1. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 1. Findings on objective and subjective sleep and awakening quality.
Saletu B; Gruber G; Saletu M; Brandstätter N; Hauer C; Prause W; Ritter K; Saletu-Zyhlarz G
Neuropsychobiology; 2000; 41(4):181-9. PubMed ID: 10828727
[TBL] [Abstract][Full Text] [Related]
2. Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole. 2. Findings on periodic leg movements, arousals and respiratory variables.
Saletu M; Anderer P; Saletu B; Hauer C; Mandl M; Oberndorfer S; Zoghlami A; Saletu-Zyhlarz G
Neuropsychobiology; 2000; 41(4):190-9. PubMed ID: 10828728
[TBL] [Abstract][Full Text] [Related]
3. Acute placebo-controlled sleep laboratory studies and clinical follow-up with pramipexole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz G; Hauer C; Saletu B
Eur Arch Psychiatry Clin Neurosci; 2002 Aug; 252(4):185-94. PubMed ID: 12242580
[TBL] [Abstract][Full Text] [Related]
4. Placebo-controlled sleep laboratory studies on the acute effects of zolpidem on objective and subjective sleep and awakening quality in nonorganic insomnia related to neurotic and stress-related disorder.
Saletu-Zyhlarz G; Anderer P; Brandstätter N; Dantendorfer K; Gruber G; Mandl M; Ritter K; Zoghlami A; Saletu B
Neuropsychobiology; 2000; 41(3):139-48. PubMed ID: 10754428
[TBL] [Abstract][Full Text] [Related]
5. Insomnia in somatoform pain disorder: sleep laboratory studies on differences to controls and acute effects of trazodone, evaluated by the Somnolyzer 24 x 7 and the Siesta database.
Saletu B; Prause W; Anderer P; Mandl M; Aigner M; Mikova O; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(3):148-63. PubMed ID: 15838186
[TBL] [Abstract][Full Text] [Related]
6. Nonorganic insomnia in generalized anxiety disorder. 2. Comparative studies on sleep, awakening, daytime vigilance and anxiety under lorazepam plus diphenhydramine (Somnium) versus lorazepam alone, utilizing clinical, polysomnographic and EEG mapping methods.
Saletu B; Saletu-Zyhlarz G; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):130-52. PubMed ID: 9313245
[TBL] [Abstract][Full Text] [Related]
7. Comparative placebo-controlled polysomnographic and psychometric studies on the acute effects of gabapentin versus ropinirole in restless legs syndrome.
Saletu M; Anderer P; Saletu-Zyhlarz GM; Parapatics S; Gruber G; Nia S; Saletu B
J Neural Transm (Vienna); 2010 Apr; 117(4):463-73. PubMed ID: 20049491
[TBL] [Abstract][Full Text] [Related]
8. Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole.
Saletu M; Anderer P; Saletu B; Hauer C; Mandl M; Semler B; Saletu-Zyhlarz G
Hum Psychopharmacol; 2001 Mar; 16(2):177-187. PubMed ID: 12404588
[TBL] [Abstract][Full Text] [Related]
9. Ropinirole treatment for restless legs syndrome.
Bogan RK
Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
[TBL] [Abstract][Full Text] [Related]
10. Insomnia in depression: differences in objective and subjective sleep and awakening quality to normal controls and acute effects of trazodone.
Saletu-Zyhlarz GM; Abu-Bakr MH; Anderer P; Gruber G; Mandl M; Strobl R; Gollner D; Prause W; Saletu B
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Feb; 26(2):249-60. PubMed ID: 11817501
[TBL] [Abstract][Full Text] [Related]
11. A dose-ranging study of pramipexole for the symptomatic treatment of restless legs syndrome: polysomnographic evaluation of periodic leg movements and sleep disturbance.
Jama L; Hirvonen K; Partinen M; Alakuijala A; Hublin C; Tamminen I; Koester J; Reess J
Sleep Med; 2009 Jun; 10(6):630-6. PubMed ID: 19171500
[TBL] [Abstract][Full Text] [Related]
12. On the pharmacotherapy of sleep bruxism: placebo-controlled polysomnographic and psychometric studies with clonazepam.
Saletu A; Parapatics S; Saletu B; Anderer P; Prause W; Putz H; Adelbauer J; Saletu-Zyhlarz GM
Neuropsychobiology; 2005; 51(4):214-25. PubMed ID: 15915004
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
14. Nonorganic insomnia in generalized anxiety disorder. 1. Controlled studies on sleep, awakening and daytime vigilance utilizing polysomnography and EEG mapping.
Saletu-Zyhlarz G; Saletu B; Anderer P; Brandstätter N; Frey R; Gruber G; Klösch G; Mandl M; Grünberger J; Linzmayer L
Neuropsychobiology; 1997; 36(3):117-29. PubMed ID: 9313244
[TBL] [Abstract][Full Text] [Related]
15. Acute double-blind, placebo-controlled sleep laboratory and clinical follow-up studies with a combination treatment of rr-L-dopa and sr-L-dopa in restless legs syndrome.
Saletu M; Anderer P; Högl B; Saletu-Zyhlarz G; Kunz A; Poewe W; Saletu B
J Neural Transm (Vienna); 2003 Jun; 110(6):611-26. PubMed ID: 12768357
[TBL] [Abstract][Full Text] [Related]
16. Ropinirole treatment for restless legs syndrome.
Chitnis S
Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922
[TBL] [Abstract][Full Text] [Related]
17. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
Allen R; Becker PM; Bogan R; Schmidt M; Kushida CA; Fry JM; Poceta JS; Winslow D
Sleep; 2004 Aug; 27(5):907-14. PubMed ID: 15453549
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of cabergoline in restless legs syndrome: a placebo-controlled study with polysomnography (CATOR).
Oertel WH; Benes H; Bodenschatz R; Peglau I; Warmuth R; Happe S; Geisler P; Cassel W; Leroux M; Kohnen R; Stiasny-Kolster K
Neurology; 2006 Sep; 67(6):1040-6. PubMed ID: 16931508
[TBL] [Abstract][Full Text] [Related]
19. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
[TBL] [Abstract][Full Text] [Related]
20. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls.
Saletu B; Anderer P; Saletu M; Hauer C; Lindeck-Pozza L; Saletu-Zyhlarz G
Sleep Med; 2002 Nov; 3 Suppl():S35-42. PubMed ID: 14592166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
